keine Finanzberatung
🔍 Search…
📊 Portfolio ← All

DVA · DaVita

S&P 500 #496 · NYSE

Risiko 5/10 · Healthcare Momentum / Policy Risk · $239.46 ▲ 1.33%

Kennzahlen

  • Price $239.46
  • Market cap $15.4B
  • P/E (ttm) 23.09
  • Div yield none
  • 52-wk range $101.00 – $241.73
  • Index rank #496 / —

Wichtigste Risiken

  • Medicare/Medicaid reimbursement rate risk (Revenue) — HIGH
  • GLP-1 drugs reducing dialysis demand long-term (Patient volumes) — MED
  • Labor cost & nursing shortages (Margins) — MED
  • Berkshire-driven valuation premium (Downside if sold) — MED

Fazit

Nation's largest kidney dialysis operator surging 83% YTD on raised guidance and strong Q1 beat; now trading at all-time highs, with GLP-1 disruption risk a key long-term watch item.

Interaktive Analyse öffnen →

Recherche, keine Anlageberatung.

⚠️ Independent research for a video, not financial advice. Figures from public sources/aggregators, can be stale; risk scores are editorial estimates. Verify before relying on any of it.